Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
about
The role of genes involved in lipolysis on weight loss program in overweight and obese individualsObesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failureAtrial natriuretic peptide in cardiovascular biology and disease (NPPA)A novel bioassay for the activity determination of therapeutic human brain natriuretic peptide (BNP)Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failureAerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.GREBP, a cGMP-response element-binding protein repressing the transcription of natriuretic peptide receptor 1 (NPR1/GCA).Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity.Exercise-related hypoglycemia in diabetes mellitusQuantification of hormone sensitive lipase phosphorylation and colocalization with lipid droplets in murine 3T3L1 and human subcutaneous adipocytes via automated digital microscopy and high-content analysis.Fatty acid signaling: the new function of intracellular lipases.Identification of a possible role for atrial natriuretic peptide in MDMA-induced hyperthermiaA genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.Activation of natriuretic peptides and the sympathetic nervous system following Roux-en-Y gastric bypass is associated with gonadal adipose tissues browning.Hormone-sensitive lipase--new roles for an old enzyme.Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytesHyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution.Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulationGene Polymorphisms of FABP2, ADIPOQ and ANP and Risk of Hypertriglyceridemia and Metabolic Syndrome in Afro-Caribbeans.Sibjotang Increases Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria.Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.Cardiovascular and metabolic effects of natriuretic peptides.Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.Changes in nitric oxide, cGMP, and nitrotyrosine concentrations over skin along the meridians in obese subjects.Insulin signalling mechanisms for triacylglycerol storage.Atrial natriuretic peptide induces postprandial lipid oxidation in humansDeterminants of intramyocellular triglyceride turnover: implications for insulin sensitivity.The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population.Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulationThe heart as an endocrine organ.Cardiac natriuretic peptides: from basic discovery to clinical practice.M-atrial natriuretic peptide: a novel antihypertensive protein therapy.Natriuretic peptides and cGMP signaling control of energy homeostasis.Endogenous ways to stimulate brown adipose tissue in humans.Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure?
P2860
Q26783026-23BEFC62-2CB2-4E51-A635-F3C718033886Q27027081-BBD70B6E-6448-4595-AFC4-046244714366Q28082833-31097D20-A8E8-415F-ABAB-265F4E44D1BEQ28485253-EC57D647-96D5-429E-B032-16EF4381E574Q28535034-B96DFB83-EAC7-4A99-83E6-4F4279CEAA8DQ33569817-ACA4B581-4D41-403B-9279-DE452D6DA5C0Q33966980-E58DD88A-7E1F-4391-88EF-96B1387D94E0Q34147708-9E590613-D887-468A-92AE-0CA9BAD1AB40Q34154607-2E838DE1-F953-4830-A02A-FDD805151A8DQ34576063-E915ED02-4325-4D05-9E29-B9CC82AE081FQ35007906-CD8C7185-49E0-4FF0-9336-77D9EF177D72Q35139141-DFD6FC77-11C2-46AF-9A39-828A4D4CCB86Q35186657-B5ED0931-AF5E-4A04-B258-54E424EFEAA2Q35283673-3F8461D0-3C9B-4B34-AE5F-3FEB559AC118Q35573512-234FCA1F-4E83-47F7-8C67-D8AA41DD76EEQ35630019-5A4708E0-8F80-4C0A-81EC-5BCD556A1D47Q35780260-DEA8668A-AD4F-41A2-833A-9CF7CA7F2C87Q35873498-F2FBA912-60B9-4EFD-814E-08F04FC0F68FQ36131187-86912502-D527-4362-BDC9-94F52AAAC5BAQ36148177-13E20238-4622-44AE-8817-057E3E969898Q36162689-5D927D33-EA4A-411B-9408-7FA5D1544E48Q36171364-1E45F97E-C2A8-4CB5-ABCB-F8FEE42441B4Q36199888-0A67A6BD-AB8E-44CE-B832-794C225645C2Q36382621-6AB25AA3-C607-4BD1-BA6C-1214DFC40900Q36498070-17B97E4F-72B5-4597-AC50-FB6568CDEC81Q36644222-B355EBD5-2492-4F20-B225-4C1E0FB8A92FQ36838847-A3E74EFF-5AEC-414D-8C61-6287293183F9Q36975436-3F291434-7F63-475C-9B5A-75040FC0441CQ37001119-C532BC8C-C9CD-49C8-A73B-E70678BA2462Q37106593-F67945C5-5B48-4520-A306-CFAFD127A34EQ37157505-9A265D2C-8BA2-4C22-8860-9C28940775B3Q37583865-803E8F7D-7650-4300-B7C3-080CE6354868Q37626852-0D7C4042-82E8-4548-9DAB-77D60E2936CCQ37632822-3566F21D-26F1-4CCA-9845-3458534E4CBAQ37703738-77569A4E-FAAD-4033-A379-6CAD95AA31D5Q37740228-39D0A943-A85B-4CB9-A40F-4E42642296A3Q37963837-BFCBD48C-C34A-45E8-B771-0A335D978B1BQ38064374-FAFF324F-0324-4311-98AB-4962463BC417Q38187493-121AB93C-95B4-4EDC-8754-66CD4A8E4DEEQ38189707-59A30614-029A-441B-A776-68326140F91D
P2860
Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Involvement of a cGMP-dependen ...... orylation in human adipocytes.
@en
Involvement of a cGMP-dependen ...... orylation in human adipocytes.
@nl
type
label
Involvement of a cGMP-dependen ...... orylation in human adipocytes.
@en
Involvement of a cGMP-dependen ...... orylation in human adipocytes.
@nl
prefLabel
Involvement of a cGMP-dependen ...... orylation in human adipocytes.
@en
Involvement of a cGMP-dependen ...... orylation in human adipocytes.
@nl
P2093
P2860
P356
P1476
Involvement of a cGMP-dependen ...... horylation in human adipocytes
@en
P2093
Anne Bouloumie
Hans Hauner
Jean Galitzky
Max Lafontan
Michel Berlan
Rudi Busse
P2860
P304
48617-48626
P356
10.1074/JBC.M303713200
P407
P50
P577
2003-09-10T00:00:00Z